Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02315625
Title Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

gastrointestinal neuroendocrine tumor

neuroendocrine tumor

islet cell tumor

pancreatic endocrine carcinoma

Therapies

Everolimus

Sunitinib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST